Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. ALHC
stocks logo

ALHC

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
960.25M
+40.95%
-0.006
-81.6%
956.15M
+38.09%
-0.018
-86.73%
956.64M
+36.42%
-0.052
-8.77%
Estimates Revision
The market is revising Upward the revenue expectations for Alignment Healthcare, Inc. (ALHC) for FY2025, with the revenue forecasts being adjusted by 1.35% over the past three months. During the same period, the stock price has changed by -26.26%.
Revenue Estimates for FY2025
Revise Upward
up Image
+1.35%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-105%
In Past 3 Month
Stock Price
Go Down
down Image
-26.26%
In Past 3 Month
9 Analyst Rating
up Image0
Wall Street analysts forecast ALHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALHC is 18.43 USD with a low forecast of 9.00 USD and a high forecast of 23.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
1 Hold
1 Sell
Moderate Buy
up Image0
Current: 13.140
sliders
Low
9.00
Averages
18.43
High
23.00
up Image0
Current: 13.140
sliders
Low
9.00
Averages
18.43
High
23.00
Baird
Michael Ha
Buy
Maintains
$17 → $22
2025-04-15
Reason
Baird
Michael Ha
Price Target
$17 → $22
2025-04-15
Maintains
Buy
Reason
Stifel
Craig Jones
Strong Buy
Maintains
$18 → $23
2025-04-08
Reason
Stifel
Craig Jones
Price Target
$18 → $23
2025-04-08
Maintains
Strong Buy
Reason
Stifel raised the firm's price target on Alignment Healthcare to $23 from $18 and keeps a Buy rating on the shares. CMS released its Final Rate Notice for 2026 after the close and the rates came in significantly above expectations, rising 283 basis points compared to the Advance Rate Notice released in January after incorporating Q4 data, the analyst tells investors.
JP Morgan
Lisa Gill
Hold
Maintains
$14 → $17
2025-03-06
Reason
JP Morgan
Lisa Gill
Price Target
$14 → $17
2025-03-06
Maintains
Hold
Reason
B of A Securities
Adam Ron
Strong Buy
Maintains
$16 → $19
2025-03-04
Reason
B of A Securities
Adam Ron
Price Target
$16 → $19
2025-03-04
Maintains
Strong Buy
Reason
Piper Sandler
Jessica Tassan
Buy
Maintains
$14 → $21
2025-03-04
Reason
Piper Sandler
Jessica Tassan
Price Target
$14 → $21
2025-03-04
Maintains
Buy
Reason
Piper Sandler raised the firm's price target on Alignment Healthcare to $21 from $14 and keeps an Overweight rating on the shares. The Alignment flywheel is gaining momentum across states, the firm says. It consists of repeatable, scalable processes and protocols that advance the four foundational goals of MA, namely expand beneficiary choice/ access, improve experience, optimize clinical outcomes, and control costs, Piper adds. The flywheel's repeatable, scalable processes and protocols establish local care delivery infrastructure and coordination, engage patients, close gaps, reduce inpatient admissions, boost quality and garner best-in-class Star Ratings for Alignment's contracts, in the firm's view.
Barclays
Andrew Mok
Sell
Maintains
$8 → $9
2025-02-28
Reason
Barclays
Andrew Mok
Price Target
$8 → $9
2025-02-28
Maintains
Sell
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Alignment Healthcare Inc (ALHC.O) is -2261.67, compared to its 5-year average forward P/E of -88.38. For a more detailed relative valuation and DCF analysis to assess Alignment Healthcare Inc 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-88.38
Current PE
-2261.67
Overvalued PE
356.41
Undervalued PE
-533.18

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-92.96
Current EV/EBITDA
41.72
Overvalued EV/EBITDA
237.04
Undervalued EV/EBITDA
-422.97

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
1.32
Current PS
0.66
Overvalued PS
2.35
Undervalued PS
0.29

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 1606.19% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

ALHC News & Events

Events Timeline

(ET)
2025-05-22
07:18:58
JPMorgan says too early to gauge impact from CMS Medicare audits
select
2025-05-20 (ET)
2025-05-20
07:54:55
Alignment Healthcare 17M share Spot Secondary priced at $15.50
select
2025-05-01 (ET)
2025-05-01
16:25:53
Alignment Healthcare CFO Thomas Freeman to step down, Jim Head to succeed
select
Sign Up For More Events
Sign Up For More Events

News

Preview
4.5
07-03NASDAQ.COM
Wednesday Sector Laggards: Hospital & Medical Practitioners, Life & Health Insurance Stocks

  • Market Performance: Life and health insurance shares are lagging behind the market, with a collective decline of about 2.3%, primarily driven by Oscar Health's drop of approximately 15% and Elevance Health's decrease of around 9.3%.

  • Sector Laggards: The video highlights hospital and medical practitioners, along with life and health insurance stocks, as the sectors underperforming on Wednesday.

Preview
2.0
05-19Newsfilter
Alignment Health Plan Recognized as One of Two Medicare Advantage Prescription Drug Plans in the U.S. for Excellence in Pharmacy Quality

  • Recognition for Quality in Medicare Advantage: Alignment Healthcare, Inc. has been awarded the PQA Laura Cranston Excellence in Quality Award for its Medicare Advantage prescription drug plan, achieving a perfect 5-star rating on all five PQA medication measures, highlighting its commitment to medication safety and adherence.

  • Commitment to Senior Care: The company emphasizes personalized support and innovative technology to enhance medication adherence among seniors, aiming to improve health outcomes while reducing costs, and has received multiple awards for its quality in pharmacy care over the years.

Preview
2.0
04-17CNBC
UnitedHealth's stock is plunging on higher medical costs. That may mean trouble for more insurers

  • UnitedHealth Group's Stock Decline: UnitedHealth Group's stock dropped 20% after the company reduced its annual profit forecast due to unexpectedly high medical costs in its Medicare Advantage plans, raising concerns for other insurers in the sector.

  • Industry Implications and Future Outlook: Analysts suggest that rising medical costs may impact companies with increased market share in Medicare Advantage, while UnitedHealth is addressing issues related to patient care utilization and government scrutiny over its billing practices.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Alignment Healthcare Inc (ALHC) stock price today?

The current price of ALHC is 13.14 USD — it has decreased -3.17 % in the last trading day.

arrow icon

What is Alignment Healthcare Inc (ALHC)'s business?

Alignment Healthcare, Inc. is a consumer-centric platform designed to improve the healthcare experience for seniors. The Company’s operations primarily consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. It partners with local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology (AVA). AVA’s capabilities include consumer experience, internal care delivery, external providers, health plan operations and growth operations. AVA offers a digital ecosystem that enables its members and their support system to get the information and care they need, when and how they need it. With their AVA-powered member portal and mobile app, seniors have many self-service capabilities and can get 24/7 care, send secure messages to their concierge and care teams, check their rewards and ACCESS On-Demand Concierge Card balance, and view their health history.

arrow icon

What is the price predicton of ALHC Stock?

Wall Street analysts forecast ALHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALHC is 18.43 USD with a low forecast of 9.00 USD and a high forecast of 23.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Alignment Healthcare Inc (ALHC)'s revenue for the last quarter?

Alignment Healthcare Inc revenue for the last quarter amounts to 926.93M USD, increased 47.46 % YoY.

arrow icon

What is Alignment Healthcare Inc (ALHC)'s earnings per share (EPS) for the last quarter?

Alignment Healthcare Inc. EPS for the last quarter amounts to -0.05 USD, decreased -80.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Alignment Healthcare Inc (ALHC)'s fundamentals?

The market is revising Upward the revenue expectations for Alignment Healthcare, Inc. (ALHC) for FY2025, with the revenue forecasts being adjusted by 1.35% over the past three months. During the same period, the stock price has changed by -26.26%.
arrow icon

How many employees does Alignment Healthcare Inc (ALHC). have?

Alignment Healthcare Inc (ALHC) has 1679 emplpoyees as of July 08 2025.

arrow icon

What is Alignment Healthcare Inc (ALHC) market cap?

Today ALHC has the market capitalization of 2.60B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free